Published in PLoS Med on January 01, 2005
Evaluation of Targeted Parasite Elimination (TPE) in Namibia | NCT02610400
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Effect of intermittent preventive treatment of malaria on health and education in schoolchildren: a cluster-randomised, double-blind, placebo-controlled trial. Lancet (2008) 2.84
Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials (2006) 2.72
Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis (2012) 2.19
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One (2009) 2.18
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? Malar J (2007) 1.72
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med (2014) 1.69
Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends. PLoS One (2009) 1.68
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother (2007) 1.64
Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J (2008) 1.59
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother (2012) 1.59
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med (2016) 1.51
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria. Antimicrob Agents Chemother (2012) 1.50
Duration of protection against malaria and anaemia provided by intermittent preventive treatment in infants in Navrongo, Ghana. PLoS One (2008) 1.48
Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. Am J Trop Med Hyg (2010) 1.41
Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev (2014) 1.38
Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J (2007) 1.34
Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS One (2010) 1.27
Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. PLoS One (2010) 1.23
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLoS Med (2012) 1.20
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS One (2010) 1.19
The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J (2005) 1.18
Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial. PLoS One (2010) 1.14
Implementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research. Open Trop Med J (2008) 1.14
A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children. PLoS One (2010) 1.11
Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy. Antimicrob Agents Chemother (2010) 1.08
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy. PLoS One (2014) 1.08
Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women. Antimicrob Agents Chemother (2009) 1.08
Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi). Malar J (2007) 1.06
The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS One (2012) 1.06
Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas. Malar J (2010) 1.06
In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation. Antimicrob Agents Chemother (2009) 1.04
Ongoing challenges in the management of malaria. Malar J (2009) 1.03
The impact of IPTi and IPTc interventions on malaria clinical burden - in silico perspectives. PLoS One (2009) 0.99
Pharmacokinetic properties of azithromycin in pregnancy. Antimicrob Agents Chemother (2009) 0.98
Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J (2014) 0.98
Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal. Malar J (2008) 0.96
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance. Malar J (2007) 0.95
Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration. PLoS One (2012) 0.95
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial. AIDS (2014) 0.95
Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children. Malar J (2010) 0.93
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Trans R Soc Trop Med Hyg (2009) 0.92
Malaria associated symptoms in pregnant women followed-up in Benin. Malar J (2011) 0.92
The interaction between seasonality and pulsed interventions against malaria in their effects on the reproduction number. PLoS Comput Biol (2015) 0.91
Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire. Malar J (2011) 0.89
The effect of timing of iron supplementation on iron absorption and haemoglobin in post-malaria anaemia: a longitudinal stable isotope study in Malawian toddlers. Malar J (2014) 0.88
The epidemiology of postpartum malaria: a systematic review. Malar J (2012) 0.87
Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends Parasitol (2013) 0.86
Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic. Malar J (2014) 0.86
Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women. Antimicrob Agents Chemother (2015) 0.85
Uncertainty in mapping malaria epidemiology: implications for control. Epidemiol Rev (2010) 0.85
Ecological niche and potential distribution of Anopheles arabiensis in Africa in 2050. Malar J (2014) 0.84
Intermittent preventive treatment for malaria in sub-saharan African: a halfway technology or a critical intervention? Am J Trop Med Hyg (2010) 0.83
In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi. Malar J (2015) 0.83
Efficacy and safety of intermittent preventive treatment for malaria in schoolchildren: a systematic review. Malar J (2015) 0.81
Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant Women. Drugs R D (2015) 0.80
Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region. Am J Trop Med Hyg (2016) 0.80
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies. PLoS One (2013) 0.79
Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy. Malar J (2012) 0.79
Pattern of the Antimalarials Prescription during Pregnancy in Bangui, Central African Republic. Malar Res Treat (2011) 0.79
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malar J (2016) 0.79
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother (2011) 0.78
Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine. PLoS One (2015) 0.78
Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective. Malar J (2015) 0.77
Does Iron Increase the Risk of Malaria in Pregnancy? Open Forum Infect Dis (2015) 0.77
Modelling malaria control. PLoS Med (2006) 0.76
Prolonged elevation of viral loads in HIV-1-infected children in a region of intense malaria transmission in Northern Uganda: a prospective cohort study. Pan Afr Med J (2010) 0.76
Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers. Antimicrob Agents Chemother (2015) 0.76
Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children. J Infect Dis (2016) 0.76
Large contractors in Africa: conundrums with malaria chemoprophylaxis. Malar J (2016) 0.75
Burden of Placental Malaria among Pregnant Women Who Use or Do Not Use Intermittent Preventive Treatment at Mulago Hospital, Kampala. Malar Res Treat (2016) 0.75
The potential benefit of scaling up malaria prevention to reduce low birth weight in Africa. PLoS Med (2017) 0.75
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep (2017) 0.75
Antimalarial drug resistance. J Clin Invest (2004) 8.50
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother (1997) 7.36
Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet (1997) 5.59
Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet (2001) 4.86
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet (1999) 3.93
Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg (1998) 3.74
Effects of Plasmodium vivax malaria in pregnancy. Lancet (1999) 3.62
Intermittent administration of iron and sulfadoxine-pyrimethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet (2002) 3.18
Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg (1992) 3.10
Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet (1988) 2.83
Antimalarial drug toxicity: a review. Drug Saf (2004) 2.76
Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg (2000) 2.61
Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Antimicrob Agents Chemother (2000) 2.54
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health (2003) 2.39
Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet (2003) 2.36
Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health (2004) 2.33
An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol (1998) 2.30
Use of intermittent presumptive treatment and insecticide treated bed nets by pregnant women in four Kenyan districts. Trop Med Int Health (2004) 2.11
The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today (1997) 2.07
Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J Infect Dis (2004) 2.06
The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg (1994) 2.05
Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg (2003) 1.92
The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. Am J Trop Med Hyg (2004) 1.88
Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Trans R Soc Trop Med Hyg (2004) 1.85
Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis (2001) 1.62
Can amodiaquine be used safely during pregnancy? Lancet Infect Dis (2004) 1.55
The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg (1990) 1.51
Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur J Clin Pharmacol (2002) 1.38
Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria. Antimicrob Agents Chemother (2003) 1.34
CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE. Br Med J (1964) 1.32
The effects of mefloquine treatment in pregnancy. Clin Infect Dis (1999) 1.21
Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis (2003) 1.15
The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy. Ann Trop Med Parasitol (1999) 1.12
More on 'the efficacy of antifolate antimalarial combinations in Africa'. Parasitol Today (1999) 1.10
Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am J Trop Med Hyg (2001) 1.08
Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ (1989) 1.03
Maloprim malaria prophylaxis in children living in a holoendemic village in north-eastern Tanzania. Trans R Soc Trop Med Hyg (1997) 1.01
Standard and reduced doses of mefloquine for treatment of Plasmodium falciparum in Tanzania: whole blood concentrations in relation to adverse reactions, in vivo response, and in vitro susceptibility. Am J Trop Med Hyg (1991) 0.90
Antimalarial drug resistance. J Clin Invest (2004) 8.50
The murine cerebral malaria phenomenon. Trends Parasitol (2009) 5.62
Cardiotoxicity of antimalarial drugs. Lancet Infect Dis (2007) 2.15
Modelling malaria control. PLoS Med (2006) 0.76